Oxurion NV

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. Show More...

Website https://www.oxurion.com
Sector Healthcare
Industry Biotechnology
Last Quote 0.90 EUR
Last Updated 09-09-2024
External Links Yahoo Finance Morningstar Ratios
Interest Coverage

The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia

	2010-12	2011-12	2012-12	2013-12	2014-12	2015-12	2016-12	2017-12	2018-12	2019-12	TTM
Earnings Per Share EUR	-0.47	-0.67	0.84	0.71	-1.42	-1.05	-1.67	0.62	-1.01	-1.35	-1.35
Dividends EUR
Payout Ratio % *
Shares Mil	30.0	33.0	36.0	37.0	37.0	37.0	37.0	37.0	39.0	39.0	39.0
Book Value Per Share * EUR	2.83	3.95	6.98	7.94	6.51	5.22	4.29	2.62	3.33	1.88	1.39
Free Cash Flow Per Share * EUR	-1.15	-0.74	0.3	0.1	-1.24	-1.05	-0.61	-0.73	0.43	-0.61
Return on Assets %	-11.42	-15.91	16.52	10.35	-20.78	-18.96	-40.13	16.75	-29.0	-57.62	-57.62
Financial Leverage (Average)	1.03	1.09	1.05	1.05	1.06	1.05	1.11	1.13	1.1	1.22	1.22
Return on Equity %	-12.02	-16.89	17.58	10.85	-21.9	-20.05	-43.12	18.8	-32.4	-65.58	-65.58
Return on Invested Capital %	-12.45	-18.64	16.42	10.28	-22.17	-20.17	-43.23	18.78	-32.52	-63.79	-63.79
Interest Coverage	-66.57							730.97
Current Ratio	23.91	7.94	14.26	15.48	11.74	13.07	7.76	7.28	9.53	5.49	5.49
Quick Ratio	23.91	7.94	13.34	14.74	10.94	12.07	7.36	6.42	9.26	5.39	5.39
Debt/Equity										0.03	0.03

Oxurion NV

Interest Coverage